Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In prostate cancer, Gal-3 has been identified as a key inhibitor for the success of immunotherapy, and its inhibition has been linked to promoting a Th1 immune response and controlling tumor recurrence
see also:
Cancer / Tumors & Galectin-3 (Gal-3)…